ATE453328T1 - Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials - Google Patents

Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Info

Publication number
ATE453328T1
ATE453328T1 AT04768179T AT04768179T ATE453328T1 AT E453328 T1 ATE453328 T1 AT E453328T1 AT 04768179 T AT04768179 T AT 04768179T AT 04768179 T AT04768179 T AT 04768179T AT E453328 T1 ATE453328 T1 AT E453328T1
Authority
AT
Austria
Prior art keywords
providing
coating material
resistant coating
improved formulation
juice resistant
Prior art date
Application number
AT04768179T
Other languages
English (en)
Inventor
Vic Young
Original Assignee
Mw Encap Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686399&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE453328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mw Encap Ltd filed Critical Mw Encap Ltd
Application granted granted Critical
Publication of ATE453328T1 publication Critical patent/ATE453328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A23P20/105—Coating with compositions containing vegetable or microbial fermentation gums, e.g. cellulose or derivatives; Coating with edible polymers, e.g. polyvinyalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Paints Or Removers (AREA)
AT04768179T 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials ATE453328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320020.1A GB0320020D0 (en) 2003-08-27 2003-08-27 Improved formulation for providing an enteric coating material
PCT/GB2004/003623 WO2005020708A1 (en) 2003-08-27 2004-08-25 Improved formulation for providing an enteric coating material

Publications (1)

Publication Number Publication Date
ATE453328T1 true ATE453328T1 (de) 2010-01-15

Family

ID=28686399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768179T ATE453328T1 (de) 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Country Status (6)

Country Link
US (2) US8846087B2 (de)
EP (1) EP1667533B2 (de)
AT (1) ATE453328T1 (de)
DE (1) DE602004024902D1 (de)
GB (1) GB0320020D0 (de)
WO (1) WO2005020708A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
US8123849B2 (en) * 2005-11-29 2012-02-28 Ideal Cures Pvt. Ltd. Aqueous film coating composition containing sodium alginate and preparation thereof
EP1837323A1 (de) * 2006-03-24 2007-09-26 SOLVAY (Société Anonyme) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluoropropan
JP2011504171A (ja) * 2007-11-13 2011-02-03 ハーキュリーズ・インコーポレーテッド 栄養補助食品および医薬品の剤形のための水分散性腸溶性コーティング配合物
EP2448566A2 (de) 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen
EP2533770B1 (de) 2010-02-12 2017-10-04 Sensient Colors LLC Enterale beschichtungszusammensetzungen sowie verfahren zu ihrer herstellung
US20110269850A1 (en) * 2010-04-28 2011-11-03 Signorino Charles A Shellac enteric coatings
IT1401146B1 (it) * 2010-07-27 2013-07-12 Gnosis Spa Composizione comprendente shellac e/o un suo sale e sodio amido glicolato
CA2808546C (en) * 2010-08-18 2018-02-20 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
SI2887925T1 (sl) * 2012-08-27 2017-06-30 Evonik Roehm Gmbh Na želodčne tekočine odporen farmacevtski ali nutracevtski sestavek z odpornostjo na vpliv etanola
ES2600860T3 (es) * 2012-08-27 2017-02-13 Evonik Röhm Gmbh Composición farmacéutica o nutracéutica con característica de liberación retardada y con resistencia contra la influencia de etanol
WO2014136857A1 (ja) * 2013-03-08 2014-09-12 ライオン株式会社 コーティング組成物、コーティング製剤及びその製造方法
WO2014177221A1 (en) * 2013-05-02 2014-11-06 Cardionovum Gmbh Balloon surface coating
PL2958607T3 (pl) * 2013-05-02 2016-12-30 Powłoka cewnika balonowego
WO2015120007A1 (en) 2014-02-05 2015-08-13 Sensient Colors Llc Surface-treated calcium carbonate, methods for making the same, and compositions including the same
US20170065528A1 (en) * 2014-03-03 2017-03-09 Sensient Colors Llc Alcohol-Resistant, Dose Dumping Protective Enteric Drug Film Coating
SG11202000445TA (en) * 2017-08-09 2020-02-27 Lion Corp Coating composition, coating film, and coating preparation and method for producing same
EP3473245A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
EP3473244A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
US20230263739A1 (en) * 2020-06-26 2023-08-24 Sensient Colors Llc Enteric coating composition and method of making and using the same
WO2023099493A1 (en) * 2021-12-03 2023-06-08 Dsm Ip Assets B.V. New delivery system for vitamin c

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126320A (en) † 1964-03-24 Enteric-coated tablets of dextran sul-
US3350329A (en) * 1967-02-01 1967-10-31 Gillespie Rogers Pyatt Co Inc Coating compositions, of shellac, melamine formaldehyde, and styrene-acrylate emulsions
AU466503B2 (en) 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
GB8308508D0 (en) 1983-03-28 1983-05-05 Ici Plc Detergent compositions
US4778749A (en) * 1984-06-01 1988-10-18 Karyon Technology, Inc. Tissue culture and production in permeable gels
US4769168A (en) 1985-08-05 1988-09-06 Colgate-Palmolive Company Low phosphate or phosphate free nonaqueous liquid nonionic laundry detergent composition and method of use
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
DE3610952A1 (de) * 1986-04-02 1987-10-08 Hagen Batterie Ag Verfahren zum herstellen von akkumulatoren mit akkumulatorplattensaetzen und nach diesem verfahren hergestellter akkumulator
AU7219094A (en) * 1993-07-14 1995-02-13 Opta Food Ingredients, Inc. Shellac dispersions and coatings, and method of making
US6083532A (en) † 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
EP1032425A1 (de) * 1997-10-31 2000-09-06 Monsanto Company Gellangummi-tablettenbeschichtungen
EP0943242A1 (de) 1998-02-26 1999-09-22 Puratos N.V. Granuliertes Brotvergesserungmittel sowie ihre Verwendung zur Herstellung von Teigwaren
KR19990072826A (ko) † 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
US6620431B1 (en) * 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
JP2002193831A (ja) † 2000-12-27 2002-07-10 Fancl Corp ヘム鉄含有経口用組成物
US6759058B1 (en) 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
KR100474945B1 (ko) * 2002-01-10 2005-03-10 알앤엘생명과학주식회사 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
EP2448566A2 (de) * 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen

Also Published As

Publication number Publication date
US20070071821A1 (en) 2007-03-29
WO2005020708A1 (en) 2005-03-10
DE602004024902D1 (de) 2010-02-11
GB0320020D0 (en) 2003-10-01
EP1667533B2 (de) 2013-07-31
EP1667533A1 (de) 2006-06-14
EP1667533B1 (de) 2009-12-30
US8846087B2 (en) 2014-09-30
US9629802B2 (en) 2017-04-25
US20140377313A1 (en) 2014-12-25

Similar Documents

Publication Publication Date Title
ATE453328T1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
TW200628159A (en) IL-12 modulatory compounds
WO2005056759A3 (en) Methods of generating variant proteins with increased host string content and compositions thereof
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ME01009B (me) Kristalni oblici dimetoksi docetaksela i postupak za njihovo dobijanje
TW200732349A (en) Anti-OX40L antibodies and methods using same
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
EA200600065A3 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
TW201713640A (en) Bruton's tyrosine kinase inhibitors
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20054093L (no) Fremgangsmate for fremstilling av keramiske partikler
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA201300330A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
TW200720256A (en) IL-12 modulatory compounds
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE102005001078A8 (de) Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver
TW200607863A (en) Immune modulating compounds from fungi
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY140061A (en) Improved method for the production of ramipril
ATE485330T1 (de) Fluoriertes polyetherpolyamin und herstellungsverfahren dafür
TW200626073A (en) Activated globular protein and its use in edible compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties